Topic resource collection
Approved comparison material connected to this topic.
57 resourcesRead both sides
Gonadorelin is synthetic GnRH — the hypothalamic hormone itself. It acts at the pituitary to stimulate LH and FSH release, sitting one step above where enclomiphene acts. The comparison highlights that enclomiphene does not add a…
A Phase II trial published in Fertility and Sterility (registered as ClinicalTrials.gov NCT01270841) compared oral enclomiphene against 1% topical testosterone gel in men with secondary hypogonadism, again finding that enclomiphe…
GLP-1 is one of two major incretin hormones. The other is glucose-dependent insulinotropic polypeptide (GIP), secreted by K-cells in the upper small intestine (the duodenum and jejunum). Together, GLP-1 and GIP account for the ma…
The phrase follistatin vs myostatin is slightly misleading, because the two are not competing drugs — they are a natural regulator and its natural antagonist locked in a physiological balance. Myostatin is produced largely by mus…
Both are lost, but fat preferentially. Across incretin studies, lean mass accounts for roughly 20–40% of total weight lost, while fat makes up the majority, so the proportion of lean mass to total mass usually rises.68 This is wh…
When GH reaches the liver, it binds the GH receptor and, via JAK2/STAT5 signaling, drives hepatic transcription of IGF-1. This liver-derived IGF-1 circulates (largely bound to IGFBP-3 and the acid-labile subunit) and accounts for…
With the family science on the table, the “adamax vs semax” question becomes clearer. The positioning is essentially rhetorical: Adamax is presented as belonging to the same ACTH-derived melanocortin lineage, so that Semax’s cred…
Distinguishing intrinsic from extrinsic aging matters because they damage the matrix through partly different molecular routes, and a peptide mechanism may be more relevant to one than the other. Intrinsic (chronological) aging i…
PE-22-28 is best understood as one member of a designed family of TREK-1-blocking peptides, each representing a different engineering trade-off. Reviewing the family clarifies why PE-22-28 in particular attracted attention. Prope…
To evaluate Cardiogen fairly, it helps to see what a well-validated cardiac peptide story looks like — and how different its evidence base is. This section is deliberately kept separate from Cardiogen’s own claims. Nothing here i…
Nowhere is LL-37’s double-edged nature more explicit than in oncology, where the peptide can either promote or inhibit tumor growth depending on tissue type, receptor context, and concentration. Overexpression of LL-37 has been a…
Claimed origin ACTH(4-7) core + Pro-Gly-Pro tail (Met-Glu-His-Phe-Pro-Gly-Pro); documented sequence Described as ACTH(4-10)-derived melanocortin analog; commercial-product sequence not established in mainstream databases Developm…
Because the two-generation distinction is so central, it is worth examining more closely how the field moved from crude extracts to defined sequences, and what that transition did and did not resolve.
The Pinealon vs Epitalon comparison is worth its own section because the two are constantly confused, yet they are structurally distinct molecules studied for overlapping but not identical hypotheses. Amino-acid sequence Glu-Asp-…
FOXO4-DRI targets cells that have already become senescent — a clearance strategy. A different research thread aims further upstream, at the telomere biology and replicative clock that can drive cells toward senescence in the fir…
The reason this comparison dominates the topic is historical as much as chemical. Both thymalin and Thymosin Alpha-1 trace back to the same basic observation of the mid-twentieth century: that the thymus produces soluble factors …
Even for Semax, it is worth being precise about tiers, because the same discipline should be applied to any Adamax claim: In-vitro / cellular — neuronal-culture and calcium-signaling studies. Informative about mechanism, not abou…